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The mouse ortholog of the Prader–Willi/Angelman syndrome imprinted domain contains several paternal-specific transcripts and the
maternally expressed gene encoding ubiquitin protein ligase E3A (Ube3a). A Large paternal Non-Coding RNA, encompassing Snurf-
Snrpn exons and the Ube3a Antisense Transcript (Ube3a-ATS), has been recently characterized and named here LNCAT. Potential roles of
LNCAT in imprinting, gene regulation, and disease are likely but have not been investigated. In order to establish the function(s) of
LNCAT, we first determined its in vivo spatio-temporal expression pattern at the cellular level during development and in different adult
brain tissues.
We show here that LNCAT is developmentally regulated, with transcript variants being specifically expressed through neuronal
differentiation in postmitotic neurons. We demonstrate that the LNCAT and Snurf-Snrpn transcripts are independent although they share
common exons. We show an absence of expression of LNCAT through gametogenesis and in early embryo excluding a role of LNCAT in the
imprint establishment. We also report a range of observations that challenges the widely accepted model of imprinted gene silencing of
Ube3a. Although these last data do not completely exclude that the LNCAT variants including ‘‘Ube3a-ATS’’exons could repress the paternal
allele of Ube3a, they do allow us to propose an alternative and consistent model.
D 2005 Elsevier Inc. All rights reserved.Keywords: Non-coding RNA; Imprinting; Prader–Willi; Angelman; Ube3a; SnrpnIntroduction
Genomic imprinting in mammals results in the differ-
ential expression of maternal and paternal alleles of a small
number of autosomal genes. The regulation of imprinted
genes is initially determined by epigenetic modifications
applied to the genomes during male or female gameto-
genesis. However, further modifications, established in early
development and later during the differentiation steps of a
specific type of cells, are necessary to read the imprinting
mark allowing a monoallelic expression of these genes
(Latham, 1999).04-Aug/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2005.07.030
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E-mail address: muscatel@ibdm.univ-mrs.fr (F. Muscatelli).Among the molecular features that have highlighted the
imprinting mechanism, the non-coding and antisense RNAs
have been frequently found within imprinted gene clusters
(Lee, 2003). Functional non-coding RNAs are implicated in
regulating several epigenetic phenomena in Arabidopsis,
Drosophila, Yeast or in X inactivation in mammals
(Andersen and Panning, 2003; Mattick, 2004). Current
thinking favors a general role of such non-coding (and
antisense) RNAS in the in the cis regulation of imprinted
genes (Delaval and Feil, 2004).
One of the most studied imprinted regions is the one
involved in the Prader–Willi (Goldstone, 2004) and Angel-
man syndromes (Clayton-Smith and Laan, 2003); both are
distinct neurogenetic disorders resulting from loss of
expression of genes located in the 15q11–q13 region.
PWS is caused by the loss of paternally expressed genes not286 (2005) 587 – 600
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interval. AS is caused by the loss or inactivation of the
maternal UBE3A allele (Kishino et al., 1997; Matsuura et
al., 1997). UBE3A encodes an E6-AP ubiquitin protein
ligase, involved in the ubiquitin–proteasome protein deg-
radation pathways (Nawaz et al., 1999). Tissue-specific
expression of UBE3A/Ube3a in human (Rougeulle et al.,
1997; Vu and Hoffman, 1997) and mouse (Albrecht et al.,
1997) shows paternal silencing in brain but not in somatic
tissues. There is evidence that Ube3a is imprinted in
neurons only (Yamasaki et al., 2003). Region-specific data
in mouse reveal that Ube3a imprinting results in complete
silencing of the paternal allele in very specific regions only,
the most evident being the cerebellar Purkinje cells and the
CA3 hippocampal neurons (Albrecht et al., 1997; Jiang et
al., 1998; Miura et al., 2002). A much stronger bias towards
the expression of the maternal allele with a low level of
expression of the paternal allele is, however, detectable
more globally in brain (Miura et al., 2002; Chamberlain et
al. 2001) (Landers et al, submitted for publication). The
latter findings suggest that the paternal allele is also
imprinted but not silenced in those regions.
The 7c mouse chromosomal region is the orthologous
region of the human PWS/AS locus. The genes, their
organization, and their imprinting regulation are similar in
both species. Imprinting mechanism share also conserved
elements in both regions. Remarkably, a cis-acting DNA
sequence called imprinting center (IC), including SNRPN/
Snrpn exon 1, has been functionally characterized. Its
paternal deletion in mouse silences the paternal expressed
genes as it has been observed in humans (Buiting et al.,
1995; Sutcliffe et al., 1994; Yang et al., 1998). This
element is required for the gametic establishment and the
postzygotic maintenance of paternal imprint (Bielinska et
al., 2000; Geuns et al., 2003; Lucifero et al., 2004).
In addition to the PWS/AS-IC that controls imprinting at
a regional level, other imprinting regulatory elements are
shared between mouse and human (Watrin et al., 2005).
Recently, we have described (Landers et al., 2004) the
organization of a large transcriptional unit encompassing the
PWS imprinting center, the gene encoding small nuclear
ribonucleoprotein N and its upstream reading frame (Snurf-
Snrpn), Ipw and the Ube3a antisense transcript (Ube3a-
ATS). This large transcriptional unit spans more than one
megabase and encodes for complex alternatively spliced
transcripts that appear to function as non-coding RNAs. All
these transcripts are exclusively expressed from the paternal
allele (Landers et al., 2004) (Fig. 1). We have named this
transcriptional unit LNCAT since no specific name was
assigned to it before. Furthermore, it is important to make
clear that Ube3a-ATS designates only one part, probably
associated to specific variants, of this transcript. Our pre-
vious findings suggest that these brain-specific non-coding
transcripts initiate in exons (exons U) that are distributed in
a 500-kb region upstream of Snurf-Snrpn. These data are
consistent with an evolutionary conserved genomic organi-zation for this transcriptional unit between human (Runte
et al., 2001) and mouse and support the hypothesis of a
conserved function of these non-coding antisense transcripts
(Landers et al., 2004). This function has not yet been
investigated. Nonetheless, distinct roles have been proposed:
(1) to serve as a host for the snoRNAs (Landers et al., 2004;
Runte et al., 2001), (2) to silence the paternal expression of
Ube3a via the Ube3a antisense transcript (Ube3a-ATS)
(Chamberlain and Brannan, 2001; Rougeulle et al., 1998),
and (3) to establish and/or to maintain the parental imprint
in the ‘‘PWS region’’ (Runte et al., 2001). Lastly, LNCAT
could result from a leakage of the RNA transcription
machinery and its biological function is questionable.
In this study, we address the question of the validity of
these hypothetical roles by investigating the developmental
and brain-structure expression patterns of LNCAT compared
to various probes.
The investigation of the spatio-temporal regulation/
expression of LNCAT in vivo, at the cellular level, is
crucial in terms of determining its function. LNCAT
encodes overlapping non-coding transcripts corresponding
to different variants (Landers et al., 2004) that might
have distinct functions. In order to clarify the regulation
and specific functions of this large non-coding transcrip-
tional unit (LNCAT), we investigate here the detailed
expression pattern of several LNCAT exons (U exons,
Ipw BE, Ipw BC, Ube3a-ATS) compared with the Snurf-
Snrpn transcript and the snoRNAs, during gametogenesis,
early development, and adulthood.Materials and methods
Mouse strains
Adult organs come from C57BL/6 mice (CERJ, France)
and embryos come from CD1 strain (Charles River
Laboratories).
RT-PCR and Northern blot analysis
Total DNase-treated RNAwas isolated from embryos and
adult tissues by using TRIzol (Life Technologies) or
RNAzol (Tel-test, Inc., Friendswood, TX). Reverse tran-
scription reactions (+RT) were performed with 2.5 Ag of
RNA and Superscripti II RNaseH reverse transcriptase
(Life Technologies) using random hexamer primers. A 2.5-
Ag aliquot of total RNA was incubated in a similar manner
but without reverse transcriptase (RT) as a control. One
twentieth of the +RT or RT was used in PCR reactions
using Taq Polymerase (Promega or Invitrogen). Oligonuc-
leotides were U consensus (5V-TCAGTGCAGCAGGTCCT-
GCT-3V); MBII52-F (5V-CTGGAAGGCATQTTCGTCC-3V);
MBII52-R (5V-CCCAAGGAGTCAACGGAC-3V); MBII85-
F (5V-CCAGGCCCTTCGGGACA-3V); MBII85-R (5V-TG-
TGCCTGACGCCCATA-3V); Ube3a-ATS L-1R (5V-ATCG-
Fig. 1. Schematic map of the mouse chromosome 7C region encompassing the large non-coding antisense transcriptional unit, extending from the U exons to
Ube3a. The variants of the Long Non-Coding Antisense Transcript (LNCAT) are initiated at different U exons and spliced to alternative LNCAT exons
including Snurf-Snrpn, Ipw, and Ube3a-ATS exons. Some potential splice variants are represented above the map. Designation of Ipw and Ube3a-ATS exons is
as in Landers et al. (2004). The snoRNAs MBII-13, MBII-85, and MBII-52 that are encoded by intronic sequences are processed from LNCAT. Paternally or
maternally expressed exonic and intronic sequences are represented respectively by black boxes/lines above or below the chromosome schematic line. The
positions of RT-PCR primers used in the studies are indicated below the map. Thus, in the 5V part, we used primers to amplify exon U/Snrpn exon 3 (specific
primers for different U exons have been designed), while in the central region, we analyzed Ipw exon B–exon C or Ipw exon B–exon E (Landers et al., 2004).
In the part overlapping Ube3a, we used two pairs of primers to amplify Ube3a-ATS exons: exon L–exon M and primers in exon M, overlapping the Ube3a
intron 12 (not indicated). We also performed the analysis on the MBII-52 and MBII-85 snoRNAs. The ISH riboprobes selected for expression studies are: exon
U2, which should detect the expression of all U exons since these latter share more than 90% of sequence identity, Ipw exons B–E and the MBII-52 and MBII-
85 snoRNAs. For Ube3a-ATS, we chose a probe in exon M of the antisense transcript, referred as Ube3a-ATS in the text. The Snurf-Snrpn transcript was
analyzed with a Snurf-Snrpn exons 1–4 probe. cen, centromere; IC, Imprinting Center; tel, telomere; Pat, Paternal chromosome; Mat, Maternal chromosome.
Primers referred as numbers are 1, U7; 2, U5; 3, U2; 4, U1; 5, Snurf exon 1; 6, Snurf exon 3; 7, MBII-85-F; 8, MBII-85-R; 9, Ipw B–F; 10, Ipw C–R; 11, Ipw
B–1R; 12, Ipw E–2F; 13, MBII-52-F, 14, MBII-52-R; 15, Ube3a-ATS L-1R; 16, Ube3a-ATS M-6F bis.
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(5V-CCAGGCTGTAAT ACATCTGTCGA-3V); Gabra5-F
(5V-ATTCACCAGGATCTTGGACGG-3V); Gabra5-R (5V-
AGCCTCAGCAGCTTGTTGGG-3 V) ; Pcp2 -F (5 V-
GTGTAACAGTTAATTCCCTGCC-3V); Pcp2 -R (5V-
TGGCTAGAQACTCTCAAGGAGC-3V). Specific annealing
temperatures and extension times are available upon request.
The oligonucleotide primers and PCR conditions for Exon
U1–Snurf exon 3 and Exon U2–Snurf exon 3 (Bressler et
al., 2001), Gapdh (Yang et al., 1998), Hprt (Boccaccio et
al., 1999), Ipw BC, Ipw BE, exon U5–Snurf exon 3, exon
U7–Snurf exon 3 (Landers et al., 2004), and Snurf exons
1–3 (Tsai et al., 1999) have been described previously.
Northern blots were performed on 15 Ag of total DNase-
treated RNA as previously described (Jay et al., 1997) and
were probed with Snurf-Snrpn exons 1–4, Ube3a-ATS, Ipw
BE, and U2 PCR products used for in situ hybridization. As
a control, mouse, b-Actin probe was amplified from cDNA
with primers: b-Actin-F: 5V-GTG GGC CGC TCT AGG
CAC CAA-3V and b-Actin-R: 5V-CTC TTT GAT GTC ACG
CAC GAT TTC-3V.In situ hybridization and immunohistochemistry
Embryos were removed from the uterus of timed
pregnant CD1 mice and dissected in RNAse free phos-
phate-buffered saline (PBS), fixed overnight in 4% paraf-
ormaldehyde (PFA) in PBS, post-fixed overnight in 15%
sucrose in PBS, embedded in OCT compound, and frozen
with liquid nitrogen vapors. C57BL/6 adult brain were
dissected and directly frozen on a copper plate on liquid
nitrogen. Frozen embryos and adult brains were sectioned
with a thickness of 12 Am in a cryostat. Embryo sections
were air dried and frozen until use whereas adult brain
sections were briefly air dried, fixed in 4% PFA for 30 min,
dehydrated and frozen until use. Sections were washed in
1 PBS, treated with RIPA buffer (150 mM NaCl, 1% NP-
40, 0.5% Na Deoxycholate, 0.1% SDS, 1 mM EDTA, 50
mM Tris pH 8), post-fixed in 4% PFA, acetylated and
further washed in PBST (1 PBS, 0.1% Tween-20) before
pre-hybridization for 1 h and overnight hybridization steps.
Pre-hybridization, hybridization, and post-hybridization
washes were performed at 70-C. Hybridization was
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solution (Sigma), 0.5 mg/ml herring sperm DNA, 0.25 mg/
ml yeast RNA. Washes were performed in 0.2 SSC.
Antisense riboprobes were transcribed with T7 RNA
Polymerase, and the digoxygenin label was detected using
anti-digoxygenin Fabs coupled to alkaline phosphatase
(Roche) and NBT/BCIP. No signal was detected with the
sense control probes. Necdin probe has been previously
described (Andrieu et al., 2003). MBII-52 and MBII-85
probes are synthetized from pUC18/T7 vector, linearized by
BamHI (Gift from J. Cavaille´). Other probes were synthe-
tized from PCR products using T7-promoter containing
primers: Snurf-Snrpn probe recognizes the first four exons
of Snurf-Snrpn that are unrelated to Snrpb; primers were
5V-GAGGAGTGATTTGCAACGC-3V and 5V-TGCTG-
TTCCACAATAGCCG-3V. Ube3a-ATS probe was designed
against intron 12 of Ube3a; primers were 5V-CTTGA-
TAACGTCTGTACTTCTG-3V and 5V-ACTTTGTACC-
CACTGTAACC-3V. Ipw BE probe was synthetized from
Ipw B-1R and Ipw E-2F primers. U2 probe should detect
the expression of all U exons since these latter share more
than 90% of sequence identity; it was synthetized from 5V-
AGTCAATTCAGTGCAGCAGG-3V and 5V-CTTGGTT-
GCTGCATTGCC-3V primers. Ube3a probe recognizes the
exon 6; primers were 5V-TATCTGGAAATGGCGTTGC-3V
and 5V-GCTCCTGAAGTGTTAATTCGC-3V. The Oct-4
control probe was synthetized from Oct-4-991: 5V-CATG-
CATTCAAACTGAGGCA-3V and Oct-4-1200: 5V-AGAA-
CAAAATGATGAGTGAC-3V primers. Specific annealing
temperatures and extension times are available upon
request.
The following primary antibodies were used: rabbit
polyclonal anti-Neurofilament M (Chemicon) and mouse
monoclonal anti-calbindin (SIGMA). Secondary antibod-
ies were Alexa 488-conjugated goat anti-rabbit IgG
antibody and peroxidase conjugated goat anti-mouse
IgG antibody.Results
The transcription of the LNCAT unit is complex and
generates numerous transcripts by alternative splicing and
from alternative 3V end usage (Landers et al., 2004). The
complexity of these transcriptional variants in terms of
structure and sequence (many of the exons are repeat
sequences) makes it difficult to perform RT-PCR amplifi-
cation in the region extending from U exons to the Ube3a-
ATS exons that overlap Ube3a. Only connection by RT-PCR
has been possible between proximal exons (Landers et al.,
2004). In our previous work using an in vitro cell culture
system, we have strongly suggested that LNCAT initiates at
the U exons (Landers et al., 2004).
To investigate the spatio-temporal expression pattern of
LNCAT, we selected the most representative RT-PCR
products in order to cover exons from the 5V, central, and3V regions of LNCAT. In parallel, we have analyzed the
Snurf exon 1–exon 3, Ube3a, and a serial of control
transcripts. A series of RNA sense and antisense probes
were tested by in situ hybridization (ISH) on mouse tissue
sections. Only the probes with target-specific signals (the
sense control probes giving no signal) have been selected
for further analysis using ISH (Fig. 1).
The expression pattern of LNCAT, snoRNAs, and
Snurf-Snrpn in adult tissues
In order to confirm that LNCAT is distinct from the
Snurf-Snrpn transcript, we used different approaches. By
RT-PCR analysis, we show that several exons of the
LNCAT are expressed in brain at birth (P0) as well as in
adulthood but not in the other tissues examined (liver,
placenta, intestine, kidney, heart) (Fig. 2A). The expression
of LNCAT appears to be correlated to that of the U exon-
containing transcripts while the Snurf transcript is
expressed in all tissues tested (Fig. 2A). By Northern blot
analysis, Snurf-Snrpn displays strong expression in adult
and P4 brain and a lower expression in other adult tissues
(Fig. 2B-a). The signal detected is a discrete band of 1.6
kb, corresponding to the size of Snurf-Snrpn bicistronic
transcript (Gray et al., 1999). These results indicate that
although the Snurf-Snrpn transcription is ubiquitous, a
higher level of expression is observed in brain. In parallel,
Northern blots analyzed with a mixture of exon U, exon
M, and Ipw BE probes revealed a hybridization smear in
adult and P4 brain only, suggesting that these antisense
exons belong to a large variety of alternative transcripts
but are independent of Snurf-Snrpn transcripts (Fig. 2B-b).
Interestingly, the exon U probe does not hybridize to the
discrete 1.6 kb fragment corresponding to the Snurf-Snrpn
bicistronic transcript suggesting that the U exons should be
rarely used as alternative exons to produce a Snurf-Snrpn
bicistronic transcript.
These data strongly suggest that LNCAT and Snurf-Snrpn
are independent transcripts.
LNCAT and snoRNAs are expressed in neurons from various
adult brain regions
RNA in situ hybridizations on mouse adult brain
sections were performed in order to define the brain
territories expressing the different exons from LNCAT, the
snoRNAs and Snurf-Snrpn. Although all are expressed in
various brain regions including the cortex, hypothalamus,
hippocampus, cerebellum, and olfactory bulb, the expres-
sion levels are variable. Regional differences in expres-
sion level are, nonetheless, detected between Snurf-Snrpn,
on the one hand, and the snoRNAs and LNCAT exons on
the other (Fig. 3A). Thus, as shown in hippocampus,
Snurf-Snrpn is highly expressed in the CA2 and CA3,
with a lower level in the dentate gyrus and CA1 (Fig.
3B-b). In contrast, exon U2, MBII-85, Ipw BE, and
Fig. 2. RT-PCR and Northern blot analysis of LNCAT, snoRNAs, and Snurf-Snrpn transcripts in mouse adult tissues. (A) RT-PCR analyses in adult mouse
tissues. Several specific primers pairs were used to detect different exonic regions of the LNCAT: U exons (U1/U2/U5/U7)–Snurf exon 3, Ipw exons B–C
(Ipw BC), Ipw exons B–E (Ipw BE), and Ube3a-ATS exons L–M (Ube3a-ATS). RT-PCR products for LNCAT as well as for the snoRNAs MBII-85 and MBII-
52 were detected only in brain (P0 and adult brain) whereas RT-PCRs Snurf-Snrpn products were detected in all the tissues examined (liver, intestine, placenta,
and heart). RNA sample integrity was controlled by amplification of an Hprt RT-PCR product. (+), with reverse transcriptase (RT); (), without RT. (B)
Northern blot analysis of mouse embryonic and adult tissues. Hybridizations were performed with a Snurf-Snrpn probe (a) or a mixture of U2, Ipw BE, and
Ube3a-ATS probes to detect LNCAT (b). No smear is detected with Snurf-Snrpn probe. Northern blots were re-hybridized with a mouse b-Actin probe in order
to quantify RNA loading. We noticed a downloading for heart, liver, and testis RNAs; however, an exposition over a longer period does not allow to detect a
signal for LNCAT in these tissues.
E. Le Meur et al. / Developmental Biology 286 (2005) 587–600 591Ube3a-ATS present a complementary expression pattern
with relatively higher expression in dentate gyrus and
CA1 as compared to the CA2 and CA3 structures (Figs.
3B-a,c,d,e). No hybridization signal was detected with all
the sense probes corresponding to the antisense probes
used in these experiments (data not shown).
The complexity of the LNCAT due to the multiple
variants initiated at different U exons (Landers et al.,
2004; Fig. 1) raises the question whether there is a
region-specific regulation of some variants potentially
linked to specific U exons. To address this difficulty,
we performed RT-PCR using specific primers designed
for each exon U. We used RNAs extracted from
olfactory bulb, cortex, hippocampus, and cerebellum
from mouse adult brain. The quality and tissue (region)specificity of cDNAs was controlled using primers for
genes specifically expressed in some of these regions
such as the gamma-aminobutyric acid receptor, subunit
alpha 5, (Gabra5), and the Purkinje cell protein 2
(Pcp2). We observe that all U exon-containing tran-
scripts are expressed in the different dissected brain
regions thus demonstrating no correlation between a
brain territory and specific exon U-containing transcript
expression (Fig. 3C).
In order to confirm an in vivo neuronal expression of
the LNCAT, we performed several double labeling
experiments using an anti-Neurofilament (NF) antibody
as a neuronal marker and specific RNA probes for
LNCAT. The neuronal marker was detected by immuno-
histochemistry whereas the different exons from the
Fig. 3. Expression analysis of LNCAT, snoRNAs, Snurf-Snrpn, and Ube3a transcripts in adult mouse brain. (A–B) In situ hybridization was performed on
sagittal sections of adult mouse brain. (A) Low magnifications of the entire brain with Snurf-Snrpn (a) and MBII-52 (b) probes. (B) Higher magnifications of
the hippocampus (a– f). LNCAT is detected with either riboprobes U2 (a), Ipw BE (d) or Ube3a-ATS (e) and is observed predominantly in the CA1 and dentate
gyrus regions, as are the snoRNAs MBII-85 (c) and Ube3a transcripts (f). In contrast, Snurf-Snrpn transcripts (b) are detected mostly in the CA2 and CA3
regions. Higher magnifications in the top right hand corners show the CA3 region of the hippocampus. Noticeably, Ube3a-ATS is not expressed at all in this
structure. CA, Cornus Ammonis; Cb, cerebellum; CC, cerebral cortex; DG, dentate gyrus; hip, hippocampus; LV, lateral ventricule; OB, olfactory bulb. (C) RT-
PCR analysis of U exon-containing transcripts in mouse brain subregions. Primers pairs used for U exons–Snurf exon 3 were as described in Fig. 2A. Gabra5
and Pcp2 were used as specific control probes for subregions: Gabra5 is expressed only in cerebral cortex, hippocampal formation, and olfactory bulb granular
layer whereas Pcp2 is restricted to Purkinje cells of cerebellum. RNA sample integrity was controlled by amplification of a Gapdh RT-PCR product. Asterisks
indicate different RT reactions. (+), with reverse transcriptase (RT); (), without RT. Ob, olfactory bulb; Cc, Cortex; Hp, Hippocampus; Cb, Cerebellum; Sp,
Spleen. (D) Neuronal-specific expression of LNCAT, snoRNAs, and Snurf-Snrpn in the mouse cerebral cortex. Simultaneous detection of LNCAT with Ipw BE
(c) or Ube3a-ATS (d) riboprobes, MBII-85 snoRNAs (b) and Snurf-Snrpn transcripts (a) by in situ hybridization (in the top right hand corner, in red) and of the
Neurofilament (NF) protein, a neuronal differentiation marker by immunohistochemistry (in the bottom left hand corner, in green) was performed on coronal
sections of adult brain. The merged images show a strict colocalization of each transcript with the Neurofilament protein. Scale bar: 1 mm (A), 250 Am (B), 80
Am for higher magnifications of CA3 (B), 10 Am (D).
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allows the colocalization of all the distinct LNCAT probes
with NF in the different brain regions (Fig. 3D).
As expected, the snoRNAs are clearly localized in the
nucleus. The other ISH probes (exon U, Snurf, Ipw BE,
Ube3a-ATS) reveal mainly cytoplasmic hybridization with
some nuclear localization observed for the Ipw BE and
Ube3a-ATS probes.The expression pattern of Ube3a-ATS relative to that of
Ube3a
The results of Fig. 3 demonstrate the widespread
expression pattern of LNCAT, including Ube3a-ATS exons,
in the brain.
In order to decipher the role of the LNCAT in the
imprinting regulation of Ube3a, we focused our analysis on
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has previously been investigated. We decided to focus our
study on the Purkinje cells and the neurons of the CA3
region of hippocampus where paternal Ube3a is silenced
with exclusive maternal expression. Identification of Pur-
kinje cells was done on morphological criteria and using an
anti-Calbindin antibody as a specific marker (Celio, 1990).
We performed a double labeling experiment using anti-
calbindin antibody by immunohistochemistry and different
LNCAT RNA probes by ISH on cerebellar sections of adult
mouse brain. We observed a clear expression of Ube3a and
U exons, Snurf-Snrpn, MBII-52 and -85, and Ipw BE in the
Purkinje cells but Ube3a-ATS is not expressed in these cells
(Fig. 4A). The lack of expression of Ube3a-ATS in the
Purkinje cells most likely results from the absence of
specific LNCAT variants since other LNCAT exons are
expressed. In order to support a correlation between the lack
of this specific antisense variant and the absence of paternal
expression of Ube3a, we analyzed the expression patterns
of Ube3a-ATS in the CA3 region of hippocampus. Again,
we did not detect any signal with the Ube3a-ATS probe in
these cells (Fig. 3B). We also designed another RNA probe
corresponding to exons L–M, overlapping the Ube3a 3V
end, and obtained the same results (data not shown).
These findings suggest that, among the transcript variants
encoded by the LNCAT, only the subset that overlaps the
Ube3a gene could be involved in the imprinting regulation
of Ube3a since other LNCAT transcripts are present in
neurons whatever the imprinted status of the paternal allele
ofUbe3a. Other key results of our analysis are that: (1) in the
few regions where the paternal allele of Ube3a is silenced,
Ube3a-ATS transcript(s) overlapping the Ube3a gene is (are)
absent and; (2) in the other brain regions, where there is a
strong bias of expression of maternal versus paternal allele,
Ube3a-ATS is expressed. We also demonstrate an expressionFig. 4. Expression of LNCAT, snoRNAs, Snurf-Snrpn, and Ube3a in the mouse ce
performed with U2 (a), Snurf-Snrpn (b), MBII-85 (c), Ipw BE (d), Ube3a-ATS (e
with an anti-calbindin antibody, a specific marker of Purkinje cells and with U
antibody labeling can be visualized as the brown-colored accumulation in the righ
cells with all the riboprobes except that for Ube3a-ATS (arrowhead). Note that alt
granule cell layer. (B) In the optic chiasma, in situ hybridizations show that Ub
neurons. Gl, granule cell layer; Pl, Purkinje cell layer. Scale bar (shown in A-a)of Ube3a-ATS in the optic chiasma and anterior commissure
regions (Fig. 4B) where Ube3a displays biallelic expression
(Albrecht et al., 1997; Jiang et al., 1998). It should be noted
that these structures (chiasma optic and anterior commissure)
contain only axons and oligodendrocytes.
The LNCAT transcriptional unit is developmentally
regulated
The expression of the LNCAT through development was
first studied by RT-PCR using RNAs extracted from whole
embryos at different developmental stages. All exons U
tested, Ipw BC, Ipw BE, MBII-52, MBII-85, and Ube3a-
ATS are expressed from 10.5 days post-coitum (dpc)
embryonic stage and have not been detected earlier (Fig.
5A). In contrast, Snurf-Snrpn is detected in blastocysts in
7.5 dpc embryos and in all later development stages tested
(Figs. 5A and B). A semi-quantitative RT-PCR analysis
shows a peak of expression at 14.5 dpc for all exons tested,
including Snurf-Snrpn (data not shown).
In 7.5 dpc embryo, no LNCAT expression was detected
by ISH with U exons or the snoRNAs probes whereas
Snurf-Snrpn was expressed in the embryonic ectoderm (Fig.
5B). In 9.5 dpc embryos, we observe Snurf-Snrpn expres-
sion in mitotic cells of the neural tube. At 10.5 dpc, it
continues to be expressed in few mitotic neurons but mainly
appears in the first appearing postmitotic neurons (data not
shown). Snurf-Snrpn expression is restricted to the nervous
system from 10.5 dpc until 14.5 dpc embryonic stages (later
embryonic stages have not been tested) although, in
adulthood, it is expressed in other tissues (Figs. 2 and
5C). All LNCAT exons tested from 10.5 dpc until 14.5 dpc
embryos are exclusively expressed in the nervous system
with a pattern similar to that previously reported for Necdin,
suggesting an expression restricted to postmitotic neuronsrebellum and optic chiasma. (A) In the cerebellum, in situ hybridization was
), and Ube3a ( f ) riboprobes. Double labeling experiments were performed
2, MBII-85, Ipw BE, Ube3a-ATS, and Ube3a riboprobes. Anti-calbindin
t hand corner of the higher magnifications. Signals are detected in Purkinje
hough Ube3a-ATS is not detected in the Purkinje cells, it is detected in the
e3a (a) and Ube3a-ATS (b) are both expressed in axons of optic chiasma
100 Am (A, B); higher magnifications (shown in A-a), 20 Am.
Fig. 5. Expression of LNCAT, snoRNAs, and Snurf-Snrpn transcripts through mouse embryogenesis. (A) RT-PCR expression analyses of LNCAT, snoRNAs, and
Snurf-Snrpn in E9.5, E10.5, E11.5, E14.5, E15.5 mouse embryos. Primer pairs used were as described in Fig. 2A. RNA integrity was controlled by amplification
of an Hprt RT-PCR product. (+), with RT; (), without RT. (B–D) In situ hybridization analyses of LNCAT, snoRNAs, and Snurf-Snrpn transcripts through
mouse embryogenesis. (B) Sagittal sections of 7.5 dpc embryos reveal that Snurf-Snrpn (b) is highly expressed in the embryonic ectoderm, whereas neither U2
(a) nor MBII-85 (c) are expressed. (C) Sagittal sections of 12.5 dpc embryos reveal that Snurf-Snrpn (a) is expressed exclusively in the nervous system, as is the
Ndn gene (b). (D) Transverse sections of 12.5 dpc embryos show that signals corresponding to U2 (b, h), Ipw BE (e, k), MBII-85 (d, j), Ube3a-ATS (f, l), and
Snurf-Snrpn (c, i) transcripts are detected in regions where the Ndn gene (a, g) is expressed: in the hypothalamus and telencephalon (a, b, c, d, e, f) and in the
mantle layer of the spinal chord (g, h, i, j, k, l). tl, telencephalon; hp, hypothalamus; v, trigeminal (V) ganglion; DRG, dorsal root ganglion. Scale bar, 200 Am (B),
1 mm (C), 500 Am (D, a– f), 200 Am (D, g– l).
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compared the expression pattern of Necdin to that of exon
U, MBII-52, MBII-85, Ipw BE, Ube3a-ATS, and Snurf-
Snrpn transcripts at 12.5 dpc embryonic stage and in the
same region of the nervous system. Predominant expression
of these transcripts is observed in ventral parts of the neural
tube, specifically in the marginal areas where differentiating
neurons reside, a pattern similar to that reported for Necdin
(Figs. 5C and D) (Andrieu et al., 2003). Nevertheless, some
differences of expression are observed in the peripheral
nervous system where Snurf-Snrpn, but not MBII-85 or
MBII-52, is expressed in cranial and dorsal root ganglia(Fig. 5D). No hybridization signal was detected with all the
sense probes corresponding to the antisense probes used in
these experiments (Supplementary Data).
LNCAT and Snurf-Snrpn are not transcribed through
gametogenesis
We next wished to study whether the LNCAT and/or
the Snurf-Snrpn transcript might play a structural role for
establishing the imprinting pattern of the entire region.
These transcripts could function in the opening of
chromatin structure of the IC (PWS-IC) throughout male
Fig. 6. Expression analyses during mouse gametogenesis. (A) RT-PCR were performed to analyze expression of LNCAT, snoRNAs, and Snurf-Snrpn in mouse
testis and ovary and compare it to their expression in brain and liver. Primer pairs used were as described in Fig. 2A, excepted for the U consensus primer which
recognizes the nine exons U described by Landers et al. [Landers, 2004 #78]. RNA integrity was controlled by amplification of an Hprt RT-PCR product. (+),
with RT; (), without RT. (B) In situ hybridizations were performed on testis (a, b) and ovary (c, d) with U2 (a, c) and Snurf-Snrpn (b, d) riboprobes. No
specific Snurf-Snrpn or U2 expression was detected in oocytes or spermatogenic cells. Oct-4 expression, used as a positive control in testis and ovaries, was
shown in the bottom right hand corner in panels b and d, respectively. Scale bar, 100 Am.
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paternal expressed genes later in embryo development. We
first investigated the expression of Snurf-Snrpn and the
LNCAT in adult ovary and testis by RT-PCR (Fig. 6A). Only
Snurf-Snrpn is expressed in testis and ovary. We then
performed an ISH on testis and ovary sections but we did
not detect any Snurf-Snrpn hybridization signal in the germ
cells (Fig. 6B). Thus, we conclude that the expression of
Snurf-Snrpn detected by PCR analysis reflects a very low
level of expression throughout the testis and the ovary but, in
both cases, there is no specific expression in male or female
gametes.Discussion
The investigation of the spatio-temporal regulation/
expression of LNCAT in vivo is crucial in terms of
determining its biological function. We have addressed this
issue in regards with the distinct putative roles that had been
assigned to LNCAT but that had never been investigated.
Our observations allow us to conclude that (1) the
LNCAT is not a spurious RNA but is developmentally
regulated throughout neurogenesis. In addition, we show
that LNCAT is expressed in postmitotic neurons and that
its subcellular localization is mainly cytoplasmic. (2)
LNCAT is not expressed in the female or male gametes
or in early development and, therefore, cannot play a
role in the establishment or maintenance of imprinting in
the PWS region and (3) the snoRNAs MBII-85 and
MBII-52 are constitutively (and not alternatively) spliced
from LNCAT. Furthermore, we make the novel observa-
tion that LNCAT and Snurf-Snrpn are distinct transcrip-
tional units.Concerning one LNCAT function as Ube3a-ATS tran-
script, we have investigated the expression pattern of
Ube3a-ATS relative to that of Ube3a.We have clearly
shown an extensive pattern of expression of Ube3a-ATS
in neurons where the paternal allele of Ube3a is
expressed, with a preferential expression of the Ube3a
maternal allele. We have also observed an expression of
Ube3a-ATS in structures where Ube3a is biallelically
expressed (chiasma optic and anterior commissure). More
importantly, in those regions where the paternal allele of
Ube3a is silenced, Ube3a-ATS is not detected. Taking
into account these and other reported findings, we will
discuss different hypotheses to explain the silencing of
the paternal allele of Ube3a and then propose an
alternative model.
LNCAT and Snurf-Snrpn are distinct transcripts but share
common exons as well as imprinting and neuronal
regulatory elements
Here, we show that, in vivo, the expression of LNCAT
is developmentally regulated with expression first
detected in the nervous system of 10.5 dpc embryos.
LNCAT expression is restricted to neurons in the
postmitotic territories during embryogenesis. In adult
brain, we have also clearly shown a neuronal specific
expression of the LNCAT exons by colocalization with a
neuronal Neurofilament marker.
Snurf-Snrpn transcripts are detected at earlier stages of
development, in the embryonic ectoderm. However, from
10.5 dpc, Snurf-Snrpn expression is restricted to the
nervous system. In adulthood, Snurf-Snrpn is expressed
ubiquitously with a significant increase in neurons.
Overall, the Snurf-Snrpn expression pattern during devel-
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LNCAT expression pattern. Our data suggest that LNCAT
and Snurf-Snrpn are distinct transcripts and are consistent
with our previous suggestion that the U exons initiate the
LNCAT (Landers et al., 2004). Furthermore, our results
strongly suggest that LNCAT and Snurf-Snrpn transcripts
could share regulatory elements such as neuronal
enhancers (Fig. 7).snoRNAs MBII-52 and MBII-85 are constitutively processed
from the LNCAT
In adult brain and during embryogenesis, we detect a
strong expression of the MBII-52 and MBII-85 snoRNAs in
postmitotic neurons, with a pattern that is identical to the
LNCAT exons (see above). The ISH signal for MBII-52 and
MBII-85 is punctate in the nucleus, indicating that we detect
E. Le Meur et al. / Developmental Biology 286 (2005) 587–600 597the mature form of these snoRNAs. These data confirm that
MBII-52 and MBII-85 are processed from the LNCAT, in all
the regions where the host transcript is expressed, suggest-
ing a constitutive splicing from this transcript rather than an
alternative splicing in a subset of regions where the host
RNA is transcribed. The question about the snoRNAs
splicing (constitutive or alternative splicing) has not been
previously addressed.
The LNCAT and imprinting mechanism
LNCAT is initiated upstream of the imprinting center and
encompasses the Snurf-Snrpn transcriptional unit, a master
regulator of the imprinting process (IC), and overlaps the
Ube3a transcript. It is conceivable to assign two potential
and non-exclusive roles to LNCAT in the imprinting
mechanism:
1) LNCAT, through the process of transcription itself, could
trigger changes in the chromatin structure. Thus, tran-
scription through the IC would activate the chromatin
subdomain that includes the paternal ‘‘PWS‘‘ expressed
genes (at least Snurf-Snrpn). Such a function for a non-
coding RNA has been proposed for the human h-globin
locus (Gribnau et al., 2000);
2) LNCAT, including Ube3a-ATS exons that overlap
Ube3a, could play a role in the imprinting (cis-silencing)
of the paternal Ube3a allele.
In terms of the first hypothetical role, we have shown by
RT-PCR and ISH that no exon of LNCAT is expressed during
gametogenesis or in early embryo. These results do not
support a role of the LNCAT in the imprinting establishment
since we would then expect an expression of LNCAT during
these stages. We conclude that LNCAT is not necessary for
imprinting establishment of the ‘‘PWS/AS domain’’ or for
Snurf-Snrpn expression in early development. It cannot be
excluded, however, that LNCAT is necessary for modifying or
remodeling the chromatin structure in postmitotic neuronsFig. 7. Cis regulation ofUbe3a imprinting model. Genomic imprinting is establishe
maternal genome. Kantor et al. proposed that the DNAmethylation status of the hum
the AS-IC (orange triangle) is dimethylated (open circles) and thus stimulates meth
genes are thus in a closed chromatin conformation. Chromatin structure is represent
three different conformations: open (slackened coiled line), semi-open (semi-coile
methylated and the PWS-IC is correspondingly unmethylated thus allowing an op
modification of the PWS domain, the Ube3a gene is, at least in early embryo, in an
could encompass the paternal allele. Later in development, there is a differential re
cells, PWS genes (Snurf-Snrpn, Necdin, Magel2...) are paternally expressed in a
tissues. There is a preferential expression of the maternal Ube3a allele but the pate
Ube3a allele will be silenced whereas PWS genes, in particular LNCAT and Snurf-
The level of expression of the paternal Ube3a allele is dependent on the type of LN
ATS overlaps Ube3a, we can speculate that the process of transcription will enable
low level of transcription. Thus, the Ube3a-ATS transcription would enable the pat
Ube3a, the paternal allele is silenced by specific neuronal factors and/or by the pate
maternal allele of Ube3a will be accessible to transcription whatever the tissue. The
indicate expression of paternally expressed genes whereas pink boxes and arrows i
the putative chromatin boundaries between the PWS domain and the AS domainthus enabling access of regulatory factors and allowing an
upregulation of Snurf-Snrpn in the central nervous system.A
role for the overlapping Ube3a antisense transcript in the
silencing of the paternalUbe3a allele has been suggested, but
not demonstrated, by the observation that the 35-kb deletion
of the ‘‘PWS-IC’’ in mouse is associated with loss of Ube3a-
ATS expression and biallelic expression of Ube3a (Cham-
berlain and Brannan, 2001). However, such a deletion would
create a maternal epigenotype in the whole 7C imprinted
region preventing the expression of all the ‘‘PWS’’ paternal
expressed genes and allowing the paternal allele of Ube3a to
be expressed as thematernal allele. This model ofUbe3a-ATS
function is based on other examples of antisense-mediated
repression (Andersen and Panning, 2003; Wang et al., 2004).
Thus, silencing could result from:
1) a post-transcriptional regulation whereby the antisense
transcript regulates the sense transcript by an RNAi
mechanism.
2) a transcriptional silencing by which the paternal Ube3a-
ATS transcript itself could recruit an enzymatic complex to
silence the chromatin structure. In this situation, RNAi
could be involved in recruitment of heterochromatin
through the interfering RNAs themselves. It has been
shown that dsRNA and proteins of the RNAi machinery
can induce transcriptional gene silencing. An alternative
way of transcriptional silencing might be that processive
transcription of Ube3a-ATS could prevent the accessibi-
lity to the regulatory elements of Ube3a and, possibly,
induce a silent chromatin state. We would then expect an
exclusive expression ofUbe3a-ATS in cells whereUbe3A
is silenced and in this case we should never detect both
transcripts in the same cell.
Thus, RNAi could regulate the paternal allele of Ube3a
through a post-transcriptional regulation or even through
a transcriptional regulation via heterochromatinization
(Matzke and Birchler, 2005). The problem with these two
RNAi-mediated silencing mechanisms is that the first step ofd during gametogenesis when a primary mark(s) is apposed to the paternal or
an AS-IC is the primary imprint (Kantor et al., 2004). On the maternal allele,
ylation (closed circles) of the PWS-IC (green triangle); paternally expressed
ed as a coiled line below the chromosome schematic line and can be found in
d line), and closed (highly coiled line). On the paternal allele, the AS-IC is
en chromatin state of the PWS genes. As a consequence of the chromatin
open chromatin structure on the maternal allele but a more closed chromatin
ading of the imprint in neuronal and non-neuronal tissues. In non-neuronal
wide range of tissues, but the level of expression is lower than in neuronal
rnal Ube3a allele is not silent. During neuronal differentiation, the paternal
Snrpn, are upregulated most likely by a neuronal enhancer (blue sun shape).
CAT variants in the different neuronal populations. In neurons where Ube3a-
the paternal Ube3a allele to be accessible for transcription factors allowing a
ernal expression of Ube3a. In those cells where no LNCAT variants overlap
rnal Ube3a locus adopting a closed chromatin conformation. In parallel, the
number of plus signs indicates gene expression level. Blue boxes and arrows
ndicate Ube3a expression. The slashes (//) on the chromatin scheme indicate
(Ube3a transcriptional unit).
E. Le Meur et al. / Developmental Biology 286 (2005) 587–600598RNAi is to produce siRNA from a dsRNA corresponding to
specific transcripts. This first step of the process requires a
Dicer activity. Currently, from what is known in mammals,
there is only one DICER and it is present in the cytoplasm
(Billy et al., 2001). The recent observation of nuclear RNAi in
mammalian cells (Langlois et al., 2005; Robb et al., 2005) is
most likely due to the import of diced siRNAs into the
nucleus. Since siRNAs are generated in cytoplasm, it is
difficult to imagine how only the paternal allele of Ube3a is
specifically silenced as we would then expect that both,
paternal and maternal, alleles should be targeted.We have
performed a detailed analysis of the expression pattern of
LNCAT variants, especially of Ube3a-ATS, in comparison to
that of paternal Ube3a expression. We have shown that
LNCAT variants, including Ube3a-ATS, are not expressed
trough gametogenesis but are expressed throughout mouse
development and in adult postmitotic neurons. Particularly,
Ube3a-ATS is detected in the brain regions, where there is a
strong expression bias of the maternal relative to the paternal
Ube3a allele and in the regions where Ube3a displays
biallelic expression (Albrecht et al., 1997; Jiang et al., 1998).
Absence of Ube3a-ATS, however, occurs only in cells where
paternal Ube3a is silenced.The absence of full-length tran-
script from germ cells and neurons does not mean there is no
siRNA (in fact, absence of long transcripts would be
consistent with siRNA presence), so that a role for siRNA
derived from the ncRNA cannot be excluded. However, our
data are not readily compatible with one of the aforemen-
tioned hypotheses to explain how Ube3a-ATS could silence
the paternal Ube3a allele.In order to integrate our novel
findings and data from the literature, we propose a new
alternative model for the role of LNCAT in imprinting
regulation (Fig. 7).
A new model for Ube3a-ATS function
There are several observations that argue against the
role of LNCAT in imprinting regulation. The first is our
demonstration that the transcription of Ube3a-ATS is
detected in cells where the paternal allele of Ube3a is
expressed but not in neurons where paternal allele of
Ube3a is silenced. Next, Rougeulle et al. have shown an
enrichment of H3K4 dimethylation within the Ube3a
promoter region (Rougeulle et al., 2003). This type of
chromatin modification appears to be characteristic of
other monoallelic expressed genes including IGF2R, a
gene that displays tissue-specific imprinting (Vu et al.,
2004). The enrichment of H3K4 dimethylation in the
Ube3a promoter is observed in ES cells even though
Ube3a is biallelically expressed in this cell type. A study
performed by RNA-FISH indicated preferential maternal
UBE3A expression in human non-neuronal tissues includ-
ing fibroblasts, lymphoblasts, and undifferentiated neuro-
nal cells (Herzing et al., 2002), where UBE3A-ATS is not
expressed (Runte et al., 2004). Altogether, these obser-
vations suggest that, in early development, Ube3a allelesare in a differential chromatin structure and are differ-
entially expressed depending on their parental origin. In
this model (Fig. 7), we propose that imprinting of the 7c
locus is established by a differential chromatin structure
during gametogenesis and/or early development. The
paternal Ube3a allele is thereby predisposed to be
silenced whereas the maternal allele is in an open
chromatin structure. During neurogenesis, the paternal
genes are upregulated and the chromatin structure of
PWS domain is in an active state. As neurogenesis
proceeds, paternal Ube3a expression is dependent on the
type of LNCAT variants in the different neuronal
populations. In neurons where Ube3a-ATS overlaps
Ube3a, the process of antisense transcription permits
the accessibility of regulatory factors and enables a low
level of paternal Ube3a transcription as it is observed. In
those cells where no LNCAT variants overlap Ube3a, the
paternal allele is silenced by specific neuronal factors
and/or by the paternal Ube3a locus adopting a closed
chromatin conformation. The novel implication of this
model is that Ube3a-ATS transcription enables the
paternal expression of Ube3a.
The precise role of LNCAT in Ube3a regulation awaits
further confirmation. In this regard, the introduction of
polyA signal to block LNCAT transcription has been
attempted (M.L., personal communication), but proved
unsuccessful, probably because of the complex pattern of
alternative promoters and alternative splicing of LNCAT.
While a functional approach is needed, our study represents
one of the few approaches that can validate or not the
proposed roles for LNCAT and potentially reveal novel
functions of this non-coding antisense transcript.Acknowledgments
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